FOR THE BEST
BRAIN & TUMOR
THERAPEUTICS
AI AND BIG-DATA DRIVEN PRECISION
NEUROLOGY AND NEURO-ONCOLOGY
view more
FOR THE BEST
BRAIN & TUMOR
THERAPEUTICS
FOR THE CURE OF REFRACTORY
BRAIN DISEASE AND CANCER
view more
FOR THE BEST
BRAIN & TUMOR
THERAPEUTICS
BRAIN-SPECIFIC THERAPEUTICS WITH
BRAIN DELIVERY PLATFORMS
view more
FOR THE BEST
BRAIN & TUMOR
THERAPEUTICS
IT’S ABOUT ALL OF US
view more

CEO’S MESSAGE

AIMEDBIO is a spin-off company from Samsung Medical Center that has been established in August 2018 with the sole purpose of pursuing after attainable treatment solutions to patients with refractory brain disease, including cancer, in hopes of providing better quality of life. Our primary objective is based on data-driven personalized treatment to address current medical unmet needs in the field of brain disease through international collaborations that we have solidified through years of close partnership. I have been continuing my journey against brain disease since 1989 as a neurosurgeon with one specific goal in mind, providing optimal solution to individual patient. Our team at AIMEDBIO has never stopped innovation for creating scientific breakthrough, technological advances and new discoveries. AIMEDBIO has been continuing its heritage of leadership in the field of brain & tumor. We have an excellent research team with profound achievements, own R&D pipelines with outstanding drug development platform and are building strong global networks with key opinion leaders in the field. We believe that our culture and challenges will be the fundamental elements of our continued success.